AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Alprostadil Cream treatment for female sexual arousal disorder to be presented.
2004 SEP 20 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it will present the new findings of a pilot clinical study conducted offshore, entitled "A Pilot Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD)."
The presentation will take place at the Annual Meeting of the International Society for the Study of Women's Sexual Health on October 28-31, 2004, in Atlanta, Georgia. Femprox is NexMed's proprietary FSAD treatment under development and incorporates alprostadil (PGE) with the patented NexACT technology.
This was a randomized, placebo-controlled, double-blind, crossover clinical study that tested eight female patients, 21-45 years of age, diagnosed with FSAD (as defined by their sexual history, Female Sexual Distress Scale, and psychological assessment) for more than 6 months. The subjects received both a placebo cream and Femprox.
The primary efficacy end point was measured as the score of the arousal success or the number of the "Yes" responses to question 3 of the female sexual encounter ...
- Antares Pharma Business Development Head Elected to Chair the Association of...
- Press release article from: PR Newswire July 22, 2004 700+ words
...and distribution companies for a number of indications and applications, including diabetes, growth disorders, obesity, female sexual dysfunction and other hormone therapy. Antares Pharma has corporate headquarters in Exton, Pennsylvania, with manufacturing...
- Examine Pharma Business Management in India as the Pharmia Industry Market is...
- Press release article from: M2 Presswire February 4, 2009 700+ words
...Research and Markets: Examine Pharma Business Management in India as the Pharmia...researchandmarkets.com/research/46a25f/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...
- Examine Pharma Business Management in India as the Pharma Industry Market is...
- Newspaper article from: Biotech Week February 18, 2009 700+ words
...researchandmarkets.com/research/ef9e33/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...come out with the report titled Pharma Business Management Insight for which an...
- Research and Markets: Examine Pharma Business Management in India as the Pharma...
- Press release article from: Business Wire February 5, 2009 700+ words
...researchandmarkets.com/research/ef9e33/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...come out with the report titled Pharma Business Management Insight for which an...
- Pharma business sold for $6.9 billion -- "BASF to focus more strongly on...
- Press release article from: M2 Presswire December 15, 2000 700+ words
M2 PRESSWIRE-15 December 2000-BASF: Pharma business sold for $6.9 billion -- "BASF to focus more strongly...agricultural products and oil and gas." After the sale of its pharma business, BASF will generate more than half of its sales in...
- Pharma Business sold for $6.9 Billion: "BASF to Foucs More Strongly on...
- Press release article from: Business Wire December 15, 2000 700+ words
...presence. This is being supplemented by a growing position in agricultural products and oil and gas." After the sale of its pharma business, BASF will generate more than half of its sales in cyclically resilient operations. BASF achieves more than two-thirds...
- Lupin acquires pharma business of Rubamin.
- News wire article from: PTI - The Press Trust of India Ltd. September 27, 2007 700+ words
Lupin acquires pharma business of Rubamin Mumbai, Sep 27 (PTI) -- Drug maker Lupin Ltd today said it has acquired the pharmaceutical business of Rubamin group...
- The Cambrex pharma business unit at Cambrex Corp. (Jobs and People).(hires...
- Magazine article from: Chemical Market Reporter July 21, 2003 700+ words
Richard D. Giles Richard D. Giles has been appointed director of business development for the Cambrex pharma business unit at Cambrex Corp. Prior to joining the company, Mr. Giles spent eight years with Chattem Chemicals Inc., where he was...
